Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents
Circulation Research. 1977;40:428-434

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cutilletta, A. F.
Right arrow Articles by Oparil, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cutilletta, A. F.
Right arrow Articles by Oparil, S.

Circulation Research, Vol 40, 428-434, Copyright © 1977 by American Heart Association

ARTICLES

Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy

AF Cutilletta, L Erinoff, A Heller, J Low and S Oparil

The effects of peripheral sympathectomy with nerve growth factor antiserum (NGFAS) on blood pressure, systemic hemodynamics, myocardial function, myocardial hypertrophy, and renin were studied in male spontaneously hypertensive (SH) rats of the Okamoto strain and normotensive control Kyoto-Wistar (WKY) rats. NGFAS prevented the developing of hypertension in the SH rats but did not alter blood pressure in the WKY rats. The NGFAS-treated SH rats developed the same hemodynamic abnormalities as the sham-treated rats, including increased peripheral vascular resistance and depressed cardiac output; Indices of left ventricular performance, including peak flow velocity, stroke power, stroke work, dP/dtmax, and flow acceleration (dF/dt), were diminished in the SH rats compared to the WKY rats. NGFAS treatment further depressed ventricular function in the SH rats, but had little effect on the WKY rats; Plasma renin activity in both the SH and WKY rats was unaffected by NGFAS treatment. Although NGFAS treatment effectively prevented the development of hypertension in the SH rats, it did not influence the development of left ventricular hypertrophy as reflected by increases in left ventricular mass, RNA, DNA, and hydroxyproline content. The data suggest that the development of myocardial hypertrophy and myocardial dysfunction in the SH rat is in part independent of hypertension and plasma renin activity.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
B. M. Palmer, Z. Chen, R. R. Lachapelle, E. D. Hendley, and M. M. LeWinter
Cardiomyocyte function associated with hyperactivity and/or hypertension in genetic models of LV hypertrophy
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H463 - H473.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
T. N. James
Circulation Today: The Coronary Arteries
JAMA, March 27, 1978; 239(13): 1302 - 1307.
[Abstract] [PDF]


Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1977 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.